Artara Therapeutics Inc (TARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,342 | -7,912 | -7,970 | N/A | N/A |
| Depreciation Amortization | 60 | 57 | 195 | N/A | N/A |
| Other Working Capital | -2,839 | 361 | -564 | N/A | N/A |
| Other Operating Activity | -3,869 | 837 | 105 | 0 | 0 |
| Operating Cash Flow | $-9,990 | $-6,657 | $-8,234 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -34,950 | -3,878 | -8,659 | N/A | N/A |
| PPE Investments | -51 | 55 | -34 | N/A | N/A |
| Sale Of Investment | 22,518 | 6,550 | 16,075 | N/A | N/A |
| Investing Cash Flow | $-12,483 | $2,727 | $7,382 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 4,339 | N/A | N/A | N/A |
| Common Stock Issued | 63,972 | 21 | N/A | N/A | N/A |
| Other Financing Activity | 24,548 | -46 | -9 | 0 | 0 |
| Financing Cash Flow | $88,520 | $4,314 | $-9 | $N/A | $N/A |
| Beginning Cash Position | 2,793 | 2,409 | 3,270 | N/A | N/A |
| End Cash Position | 68,840 | 2,793 | 2,409 | N/A | N/A |
| Net Cash Flow | $66,047 | $384 | $-861 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,990 | -6,657 | -8,234 | N/A | N/A |
| Capital Expenditure | -51 | -10 | -67 | N/A | N/A |
| Free Cash Flow | -10,041 | -6,667 | -8,301 | 0 | 0 |